Clinical trial in patients with VIN3 disease - comparison of efficacy of developed vaccine

In 2008 we have started a trial in patients with VIN3 disease (similar to the Phase I/II clinical trial on the use of long peptides plus adjuvant for end-stage cervical cancer or VIN patients), in which we are comparing the efficacy of this vaccine with or without local application at the vaccination site of the TLR ligand imiquimod (Aldara). Results and data will become available.

created over 15 years ago (16 December 2009)    last modified over 12 years ago (4 January 2013)   [ RDF ]   [ RelFinder ]